BSE filing, NSE: ABAN. Summary written from the filing by ALFA Finder's alert engine.
Aban Offshore Ltd: key numbers
- Share price
- ₹13.94
- Market cap
- ₹81.36 Cr
- Revenue (annual)
- ₹409.6 Cr
- Net profit (annual)
- ₹-528.9 Cr
- P/E (TTM)
- -0.4×Sector 18.3×
- Promoter holding
- 46.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aban Offshore Ltd
All →Aban Offshore Annual Report
Aban Offshore filed its Annual Report for FY 2025-26, including the 40th AGM notice for 16 November 2026. The company remains under CIRP with powers suspended.
Aban Offshore Annual General Meeting
Aban Offshore has issued the notice for its 39th AGM on 16 November 2026. Agenda covers adoption of FY25 financials, director re-appointment, and secretarial auditor appointment.
Aban Offshore Debt & Borrowing: ₹281 Cr
Aban Offshore Limited reported that Rs. 281 Crore in preference shares remain unredeemed since 2014. The company has set-off a Rs. 18 Crore liability against amounts utilized by Axis Bank.
- Value
- ₹281.0 Cr
Aban Offshore Q1 FY27 Results: Turns Profitable, Net Profit ₹83.7 Cr
Aban Offshore Ltd reported revenue from operations of ₹165.3 Cr (+44.5% YoY) and net profit of ₹83.7 Cr for Q1 FY27.
- Key figure
- Net profit ₹83.7 Cr
Aban Offshore Other Announcement
Aban Offshore clarified that no board meeting occurred on August 14, 2026, as the company is under CIRP. Financials were signed by the Resolution Professional.
Aban Offshore Q4 FY26 Results: Turns Profitable, Net Profit ₹1.8 Cr
Aban Offshore Ltd reported revenue from operations of ₹99.1 Cr (-14.3% YoY) and net profit of ₹1.8 Cr for Q4 FY26.
- Key figure
- Net profit ₹1.8 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.